Stocks / NASDAQ / Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc.

Our Opinion

Osiris Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.

“Prochymal is currently being evaluated in clinical trials for the preservation and improvement of cardiac function following an acute myocardial infarction, or heart attack. Prochymal has been demonstrated in animal models to prevent pathologic remodeling or scar formation in the infarcted area of the heart.” Read the following article

Company Description

Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products. Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair. [Source: MarketWatch]

Company Website: